PO&T Risk Management Lead

About This Role As the PO&T Risk Management Lead, you will establish and lead integrated risk management processes to identify top-level risks across PO&T accountabilities. You will synthesize, escalate, and communicate technology, quality, supplier, safety, environmental, product supply, compliance, and emerging risks to PO&T leadership, collaborating across Biogen’s manufacturing and supply network using standardized risk assessment frameworks. You will approve mitigation plans for critical risks and report on organizational preparedness. What You’ll Do Develop and implement methodologies to identify and assess systemic risks across PO&T. Lead synthesis of functional and site risk assessments for PO&T leadership. Collaborate cross-functionally to identify risks and vulnerabilities. Track mitigation implementation and recommend adjustments. Integrate risk management into manufacturing and supply chain planning. Develop supply chain continuity and resilience strategies. Run business continuity simulations and lead crisis response efforts. Prepare and present risk management reports. Required Skills Master’s Degree in Science, Engineering, Supply Chain Management, Business Administration, or similar. 10+ years’ experience; at least 2 years in risk management within biotech/pharmaceutical. Strong leadership and matrix influence; excellent analytical, problem‑solving, and communication skills. Ability to distill complex information into key points. Experience in executive governance forums. Preferred Skills Leading risk efforts impacting product supply and business continuity. Familiarity with Enterprise Risk Management. Post-crisis analysis and lessons learned. Benefits/Compensation (as stated) Base pay range: $151,000–$208,000. Short/long-term incentives (cash bonus and equity opportunities). Medical, dental, vision, life; fitness reimbursement; disability; paid vacation; holidays; sick time; paid parental leave; 401(k) match; stock purchase plan; tuition reimbursement (up to $10,000); ERG participation. #J-18808-Ljbffr Scorpion Therapeutics